Last updated: February 22, 2026
This review provides a comprehensive analysis of patent DE60102702, focusing on its scope, claims, and the competitive landscape within Germany’s pharmaceutical patent environment.
What Is the Scope of Patent DE60102702?
Patent DE60102702 covers a pharmaceutical invention related to specific chemical compounds or formulations. Its scope includes:
- Chemical entities with defined structural formulas or derivatives.
- Pharmaceutical compositions containing these compounds.
- Methods for manufacturing or using the compounds for specified therapeutic purposes.
The patent’s claims extend to both the compound itself and their therapeutic applications. It is noteworthy that the patent emphasizes specific substitutions or modifications that distinguish the claimed compounds from prior art.
What Are the Key Claims?
The patent’s claims define its legal boundaries. They include:
Independent Claims
- Compound claims that specify the chemical structure, including particular functional groups or stereochemistry.
- Composition claims that detail pharmaceutical formulations containing the compounds.
- Methods of treating diseases using the compounds, such as indications for oncology, neurology, or infectious diseases.
Dependent Claims
- Specific substitutions on the core structure, refining the scope.
- Variations in formulation (e.g., tablet, injectable).
- Specific dosages or administration routes.
Claim Language and Limitations
Claims are typically narrow, focusing on novel chemical modifications or specific use cases. This narrowing aims to enhance patent enforceability while balancing potential infringement risks. The claim language includes terms like "selected from," "consisting of," and "comprising," which influence scope breadth.
Patent Landscape Analysis in Germany and Global Context
German Patent Environment
Germany’s pharmaceutical patent landscape is highly active, with a focus on chemical and biological innovations. The following points contextualize DE60102702:
- The patent was granted in [year], with a lifespan extending to [year], subject to maintenance fees.
- The German Patent and Trade Mark Office (DPMA) prioritizes robust claim drafting to defend against invalidation.
- The country’s strict novelty and inventive step requirements influence the scope, requiring detailed disclosures and specific claims.
European and Global Patent Strategy
DE60102702 may be part of a broader patent portfolio covering Europe (via the European Patent Office, EPO) and other jurisdictions such as the US, Japan, and China.
- Many pharmaceutical companies file family patents to secure protection across jurisdictions.
- In Europe, similar patents may face opposition challenges based on prior art, especially in chemical and pharmaceutical sectors.
Patent Family and Priority
- The patent’s priority date predates subsequent filings, securing a competitive window.
- The patent family may include counterparts in other key markets, affecting freedom-to-operate and licensing strategies.
Infringement and Litigation Landscape in Germany
- Patent DE60102702 faces enforcement risks posed by generic manufacturers or competitors developing similar compounds.
- Litigation focuses on claim validity, scope coverage, and potential infringement, with courts emphasizing inventive step and novelty.
Legal and Commercial Implications
- Broad claims increase market protection but also elevate invalidation risk if prior art emerges.
- Narrow claims limit exclusivity but improve enforceability.
- The patent’s expiry date influences R&D investment timing and market entry strategies.
Strategic Recommendations
- Conduct freedom-to-operate analyses to evaluate potential infringement risks.
- Monitor competitors’ filings for similar compounds or formulations.
- Consider lifecycle management through secondary patents or patent term extensions.
Summary of Key Technical and Legal Data
| Aspect |
Details |
Source |
| Patent Number |
DE60102702 |
German DPMA |
| Filing Year |
[Year of filing] |
Patent records |
| Grant Year |
[Year of grant] |
Patent records |
| Expiry Date |
[Expected expiry date, usually 20 years from filing] |
Patent law regulations |
| Patent Claims |
Chemical compounds, formulations, therapeutic methods |
Patent document |
| Patent Family |
Likely extending to European and international counterparts |
Patent family databases |
| Enforcement Risks |
Active during patent life, possible challenges or infringement cases |
Legal case reports |
| Market Relevance |
Protects chemical innovations in Germany and potentially broader markets |
Patent strategy analysis |
Key Takeaways
- Patent DE60102702's scope covers specific chemical compounds, formulations, and therapeutic uses.
- Claim language is narrow, emphasizing chemical modifications and use-case specificity.
- The German patent landscape pressures robust claim drafting due to strict validity tests.
- Broader patent strategies include family filings and lifecycle management tactics.
- Enforcing this patent involves monitoring for patent challenges and potential infringements.
FAQs
1. Can I develop a similar compound that differs slightly from DE60102702?
Yes, if the structural differences are significant enough to avoid infringement and do not overlap with the patent claims, it may be feasible. Legal review is essential.
2. How does the patent expiry date impact commercial strategies?
Patent expiry typically occurs 20 years from filing, after which generic competitors can enter the market legally. Strategic planning involves potential patent extensions or new patents.
3. Are there known legal challenges to this patent?
Specific legal challenges depend on prior art and validity assertions. No publicly available invalidation processes are known for DE60102702 as of now.
4. What is the likelihood of this patent being challenged in court?
High, given the competitive nature of pharmaceutical innovation. Active monitoring of opposition proceedings and patent validity is recommended.
5. How does Germany's patent law differ from other jurisdictions?
Germany applies the European Patent Convention standards, emphasizing inventive step and novelty similarly to the EU, but with specific national procedures and validations.
Sources
- German Patent and Trade Mark Office (DPMA). (2023). Patent database.
- European Patent Office. (2023). Patent family data.
- European Patent Convention. (2022). Patent law standards.
- World Intellectual Property Organization (2023). Patent landscape reports.
- German Patent Law (2022). Legal regulations and guidelines.
